A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone

Validated biomarkers are needed to improve risk assessment and treatment decision-making for women with ductal carcinoma in situ (DCIS) of the breast. The Oncotype DX(®) DCIS Score (DS) was shown to predict the risk of local recurrence (LR) in individuals with low-risk DCIS treated by breast-conserv...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Breast Cancer Res Treat
Auteurs principaux: Rakovitch, Eileen, Nofech-Mozes, Sharon, Hanna, Wedad, Baehner, Frederick L., Saskin, Refik, Butler, Steven M., Tuck, Alan, Sengupta, Sandip, Elavathil, Leela, Jani, Prashant A., Bonin, Michel, Chang, Martin C., Robertson, Susan J., Slodkowska, Elzbieta, Fong, Cindy, Anderson, Joseph M., Jamshidian, Farid, Miller, Dave P., Cherbavaz, Diana B., Shak, Steven, Paszat, Lawrence
Format: Artigo
Langue:Inglês
Publié: Springer US 2015
Sujets:
Clinical Trial
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4491104/
https://ncbi.nlm.nih.gov/pubmed/26119102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-015-3464-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires